Next-generation sequencing and HIV drug resistance surveillance
Circulating drug-resistant HIV-1 variants in antiretroviral-naive populations are on the rise in regions where access to antiretroviral therapy (ART) has recently been scaled up, particularly in low-income and middleincome countries (LMICs).1,2 This increase threatens the success of national ART pro...
Main Authors: | Hamers, R, Paredes, R |
---|---|
Format: | Journal article |
Published: |
Elsevier
2016
|
Similar Items
-
Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations
by: Santiago Ávila-Ríos, et al.
Published: (2020-06-01) -
HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique.
by: María Rupérez, et al.
Published: (2018-01-01) -
Surveillance of carbapenem-resistant organisms using next-generation sequencing
by: Katelin V. Gali, et al.
Published: (2023-05-01) -
Pan-resistant HIV-1: what's next?
by: Hamers, RL, et al.
Published: (2020) -
Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance Genotyping
by: Neil T. Parkin, et al.
Published: (2020-06-01)